Your browser doesn't support javascript.
loading
Antimicrobial Efficacy of Biogenic Cobalt and Copper Nanoparticles against Pathogenic Isolates.
Liaqat, Iram; Ali, Rabbia; Hanif, Uzma; Latif, Asma; Bibi, Asia; Saleem, Sadiah; Naseem, Sajida; Ulfat, Mobina; Mubin, Muhammad; Rashid, Farzana.
Afiliação
  • Liaqat I; Microbiology Lab, Department of Zoology, Government College University.
  • Ali R; Microbiology Lab, Department of Zoology, Government College University.
  • Hanif U; Department of Botany, Government College University.
  • Latif A; Department of Zoology, Lahore College for Women University.
  • Bibi A; Department of Zoology, The Women University.
  • Saleem S; Department of Microbiology, University of Karachi.
  • Naseem S; Department of Zoology, Division of Science and Technology, University of Education.
  • Ulfat M; Department of Botany, Lahore College for Women University.
  • Mubin M; Centre of Agricultural Biochemistry and Biotechnology, University of Agriculture.
  • Rashid F; Department of Zoology, Lahore College for Women University.
J Oleo Sci ; 71(11): 1669-1677, 2022.
Article em En | MEDLINE | ID: mdl-36310054
ABSTRACT
Biogenic synthesis of cobalt (Co) and copper (Cu) nanoparticles (NPs) was performed using the bacterial strains Escherichia coli and Bacillus subtilis. Prepared NPs were confirmed by a color change to maroon for CoNPs and green for CuNPs. The NPs characterization using FTIR showed the presence of functional groups, i.e., phenols, acids, protein, and aromatics present in the Co and CuNPs. UV-vis spectroscopy of E. coli and B. subtilis CuNPs showed peaks at 550 and 625 nm, respectively. For E. coli and B. subtilis CoNPs, peaks were observed at 300 nm and 350 nm, respectively. Antibacterial and antifungal activity of B. subtilis and E. coli Co and CuNPs was determined at 100 mg/mL concentration against two bacterial strains at 5, 2.5, and 1.5 mg/mL against fungal two strains F. oxysporum and T. viridi, respectively. B. subtilis CuNPs showed significantly higher inhibition zones (ZOI=25.7-29.7 mm) against E. coli and B. subtilis compared to other biogenic NPs. Likewise, B. Subtilis CuNPs showed lower MIC (4.3 ± 6.3) and MBC (5.3 mg/mL) values against both tested isolates. Antifungal activity of B. subtilis and E. coli CuNPs and CoNPs showed a concentration-dependent decrease in ZOI. Among all biogenic NPs, B. subtilis CoNPs showed the highest ZOI (25-30 mm) against F. oxysporum followed by E. coli CuNPs with maximum ZOI (20-27 mm) against T. viridi. Again, B. subtilis CoNPs and E. coli CuNPs showed lowest MIC and MFC values against both fungal isolates. In conclusion, the current study showed that biogenically synthesized B. subtilis Cu or CoNPs can be used as effective antimicrobial agents due to their potential antibacterial and antifungal potential.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas Metálicas / Anti-Infecciosos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas Metálicas / Anti-Infecciosos Idioma: En Ano de publicação: 2022 Tipo de documento: Article